NeVa at SFNR2025
This week at SFNR, Prof. Dr. Sébastien Soize from CHU de Reims shared the inspiring journey of NeVa, highlighting its early trials, the CLEAR study, and emphasizing its exceptional first-pass success rates along with its strong safety profile. Prof. Soize also announced that NeVa, with its exclusive Drop Zone technology, is now reimbursed in France and accessible to all.
Prof. Vincent Costalat, President of SFNR, provided additional insights from the Montpellier experience, highlighting NeVa’s outstanding performance, particularly in cases involving hard and complex clots.
A heartfelt thank you to Dr. Soize and Dr. Costalat for their trust in NeVa and for sharing their experiences.
NeVa is CE-marked.
Prof. Vincent Costalat, President of SFNR, provided additional insights from the Montpellier experience, highlighting NeVa’s outstanding performance, particularly in cases involving hard and complex clots.
A heartfelt thank you to Dr. Soize and Dr. Costalat for their trust in NeVa and for sharing their experiences.
NeVa is CE-marked.
